Skip to main content
SpringerLink
Log in

Imaging for prostate cancer: reimbursements

  • Perspective
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Turkbey B, Brown AM, Sankineni S, et al (2015). Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer. CA Cancer J Clin 00:00-00.

    Google Scholar 

  2. Radtke JP, Schwab C, Wolf MB, et al (2016). Multiparametric magnetic resonance imaging (MRI) and MRI-transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy specimen. Eur Urol. Nov 70(5):846-853.

  3. El- Shater Bosaily A, Parker C, Brown LC, et al (2015). PROMIS-Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer. Contemp Clin Trials. 42:26-40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bjurlin MA, Carroll PR, Eggener S, et al (2019). Update of the standard operating procedure on the use of multiparametric magnetic resonance imaging for the diagnosis, staging, and management of prostate cancer. J Urol. 101097JU0000000000000617.

  5. Sidana A, Watson MJ, George AK, et al (2018). Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: a multi-institutional analysis. Urol Onc. Jul;36(7):341.e1-341.e7

  6. Wegelin O, Exterkate L, van der Leest M et al (2019). The FUTURE trial: a multicenter randomized controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies. Eur Urol. 75: 582-590/

  7. Sonn GA, Chang E, Natarajan et al (2014). Value of targeted biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol. 65:809-815.

    Article  PubMed  Google Scholar 

  8. Valerio M, Donaldson I, Emberton M et al (2015). Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review. Eur Urol. 68:8-19.

    Article  PubMed  Google Scholar 

  9. Shah TT, Peters M, Eldred-Evans D, et al (2019). Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry. Eur Urol. 76(1):98-105.

    Article  PubMed  Google Scholar 

  10. Guillaumier S, Peters M, Arya M, et al (2018). A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer. Eur Urol. 74(4):422-429

    Article  PubMed  PubMed Central  Google Scholar 

  11. van den Bergh RC, Ahmed HU, Bangma CH et al (2014). Novel tools to improve patient selection and monitoring on active surveillance for prostate cancer: a systematic review. Eur Urol. 65(6): 1023-31.

    Article  Google Scholar 

  12. Guo R, Cai L, Fan Y et al (2015). Magnetic resonance imaging on disease reclassification among active surveillance candidates with low-risk prostate cancer: a diagnostic meta-analysis. Prostate Cancer Prostatic Dis. May; 18: 221–228. https://doi.org/10.1038/pcan.2015.20

  13. Rosenkrantz AB, Verma S, Choyke P et al (2016). Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement of the American Urological Association and the Society of Abdominal Radiology’s Prostate Cancer Diseases Focused Panel. J Urol. Dec; 196 (6): 1613-1618.

  14. Mohler JL, Antonarakis ES, Armstrong AJ et al (2019). Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. May; 17:479–505

  15. Booker MT, Silva E 3rd, Rosenkrantz AB (2019). National Private Payer Coverage of Prostate MRI. J Am Coll Radiol. 16(1):24-29.

    Article  PubMed  Google Scholar 

  16. Rosenkrantz AB, Lepor H, Huang WC, Taneja SS (2016). Practical Barriers to Obtaining Pre-Biopsy Prostate MRI: Assessment in Over 1,500 Consecutive Men Undergoing Prostate Biopsy in a Single Urologic Practice. Urol Int. 97(2):247-248.

    Article  PubMed  Google Scholar 

  17. Rosenkrantz AB (2014). Regional variation in medicare imaging utilization and expenditures: 2007-2011 trends and comparison with other health services. J AM Coll Radiol. Jan;11(1):45-50.

  18. Rosenkrantz AB, Chu S, Choyke PL et al (2019). Prostate MRI model policy. American College of Radiology. https://www.acr.org/-/media/ACR/Files/Advocacy/AIA/Prostate-MRI-Model-Policy72219.pdf. Accessed 25 December 2019.

  19. Rosenkrantz AB, Degnan AJ, Duszak R (2018). Documentation, coding, and billing: what abdominal radiologists need to know. Abdom Radiol. 43(3):734-741.

    Article  Google Scholar 

  20. What is MRI with Transrectal Ultrasound Fusion-Guided Prostate Biopsy and How is it Coded? https://community.auanet.org/blogs/policy-brief/2017/10/18/what-is-mri-with-transrectal-ultrasound-fusion-guided-prostate-biopsy-and-how-is-it-coded. Accessed 27 December 2019.

Download references

Author information

Authors and Affiliations

  1. Division of Urology, Department of Surgery, University of Cincinnati Medical Center, University of Cincinnati College of Medicine, 234 Goodman Street, Cincinnati, OH, 45267-0761, USA

    Connor Hoge & Abhinav Sidana

  2. Department of Radiology, University of Cincinnati College of Medicine, Cincinnati, OH, USA

    Sadhna Verma

Authors
  1. Connor Hoge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abhinav Sidana
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sadhna Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Connor Hoge.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hoge, C., Sidana, A. & Verma, S. Imaging for prostate cancer: reimbursements. Abdom Radiol 45, 4114–4116 (2020). https://doi.org/10.1007/s00261-020-02443-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-020-02443-4

Search

Navigation